Co-Authors
This is a "connection" page, showing publications co-authored by Luisa Imberti and Helen Su.
Connection Strength
0.349
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
Score: 0.060
-
Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Immunol Cell Biol. 2021 10; 99(9):917-921.
Score: 0.060
-
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell. 2021 04 01; 184(7):1836-1857.e22.
Score: 0.058
-
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
Score: 0.058
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057